CAR T cell neurotoxicity: hope is on the horizon.
In this issue of Blood Karschnia et al spotlight the "Achilles heel" of chimeric antigen receptor (CAR) T cell therapy and call for prospective clinical trials to evaluate strategies to manage and potentially prevent CAR T cell induced neurotoxicity (NT) 1
Blood